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Cell Proliferation and Carcinogenesis Models:
General Principles with Illustrations from the
Rodent Liver System
by Suresh H. Moolgavkar
Rates of cell proliferation, cell death, and cell differentiation affect the risk of cancer pro-
foundly. An increase in cell proliferation rates leads to an increase in mutation rates per unit of
time, which, in turn, leads to an increase in the risk ofcancer. An increase in cell division rates
relative to death or differentiation rates may lead to an increase in the population of critical
target cells, which, again, leads to an increase in cancer risk. These fundamental principles are
well illustrated by the rodent liver model for carcinogenesis. In this paper I briefly discuss
some of the consequences of incorporating cell proliferation kinetics into quantitative models
ofcancer risk assessment. Consideration ofcell kinetics can shed light on apparently paradoxi-
cal observations, such as the observation that the administration of two different promoters
may lead to the same volume fraction in the rodent liver, with one promoter giving rise to a
large number of small foci and the other to a small number of large foci. Another observation
that can be illuminated by a consideration ofcellular proliferation kinetics is the phenomenon
ofthe inverse dose-rate effect. It has been observed with exposure to high LET radiation and to
certain chemicals that fractionation ofa given total dose ofthe agent leads to an increased life-
time probability of tumor. A biological explanation of this finding can be given in terms of the
effect ofthe agent on cell proliferation kinetics.
Introduction
There is now considerable evidence that the somatic
mutation theory of carcinogenesis is essentially cor-
rect. At the same time, there is increasing appreciation
that cell proliferation kinetics play a critical role in
malignant transformation (1). Cell proliferation may
affect the risk of cancer in one or more of at least two
ways. First, an increase in the rate of cell proliferation
may lead to an increase in the rate ofmutation per unit
time and thus to an increase in the risk of cancer.
Second, an increase in cell division relative to cell dif-
ferentiation or cell death may lead to an increase in the
population of cells susceptible to malignant transfor-
mation, which, in turn, has the most profound effect on
cancer risk. In this paper, I present some ofthe gener-
al principles that arise as a natural consequence of con-
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sideration ofcell kinetics in quantitative models ofcar-
cinogenesis.
There is now clear-cut evidence that programmed
cell death, or apoptosis, isjust as important as cell divi-
sion in determining cancer risk. Some promoters may
inhibit apoptosis (2) and some oncogenes may do the
same (3). Thus, it is important to explicitly consider
apoptosis in mathematical models that incorporate cell
proliferation kinetics. There is a mistaken impression
(1) that, in mathematical models with cell kinetics, it is
sufficient to consider only the net rate of growth of
cells, i.e., it is sufficient to consider the difference
between the rate of cell division and the rate of cell
death. This is false, as I will try to illustrate by means
of examples. Similarly, some so-called simulation mod-
els (1) consider only the mean number of cells in each
ofthe stages on the pathway to malignancy. This again
leads to erroneous results: stochastic considerations
cannot be ignored.
The Model
Most of my qualitative conclusions are general and
do not depend on a specific model of carcinogenesis.
Quantitative conclusions are based on a simple model
for chemical carcinogenesis (Fig. 1).S. H. MOOLGAVKAR
t p(s)
~~v(s)X(s) (>convers'ion
s~:: initiation (s K(
promotion
FIGURE 1. Graphical representation ofthe two-mutation model.
Initiation and Conversion
The model assumes that normal target cells are
transformed into cancer cells via an intermediate stage
in two rate-limiting, irreversible, hereditary (at the
level of the cell) steps. Intermediate cells are assumed
to be generated from normal cells as a nonhomoge-
neous Poisson process with intensity v(s)X(s), where
v(s) can be thought of as the rate of initiation per cell
per unit time and X(s) is the number ofnormal cells at
risk at time s. The second step is the conversion of
intermediate cells into malignant cells with rate ,u(s)
per cell and unit time. Precisely, an intermediate cell
divides into one intermediate cell and one malignant
cell with rate j(s).
Promotion
The salient feature of promotion is assumed to be
growth (clonal expansion) of intermediate cells as a
stochastic birth-death process with cell division rate
a(s) and death (differentiation) rate 1(s). Details ofthe
model can be found elsewhere (4,5).
Some Consequences of Explicitly
Considering Cell Division and Cell
Death
If the rate of apoptosis is greater than zero, then
there is a non-zero probability that an initiated cell will
die without giving rise to a detectable lesion such as a
papilloma on the skin or an altered focus in the liver.
To some biologists, this conclusion may come as a sur-
prise, because the irreversibility ofinitiation is current
dogma. I am not suggesting that individual initiated
cells revert to the normal phenotype, but because
some initiated cells die, initiation is partially reversible
on the level ofthe organ. Because normal cells that are
initiated (altered) may die without giving rise to foci, it
is impossible to determine from the number of observ-
able foci alone how strong the initiating action of an
agent is (6,7).
For the sake of simplicity, let us assume that the
rates of cell division and apoptosis are constant. Then,
the probability that an initiated cell and all its progeny
die is given (asymptotically) by the ratio ofthe apopto-
sis rate and the cell division rate. Ifthe rate ofapopto-
sis is larger than the cell division rate, then the
(asymptotic) probability of extinction is 1. However,
some foci may still be visible because ofthe stochastic
nature ofthe process. In recent analysis ofaltered foci
in the rat liver, we conclude that the vast majority
(approximately 90%) of initiated cells die without giv-
ing rise to foci (8). Some support for this conclusion is
provided by the observations of Satoh and colleagues
(9) and more recently by those of Schulte-Hermann
(10) on the time-course of the number of GST-P-posi-
tive single cells following initiation. From his data,
Schulte-Hermann estimates that approximately 80% of
GST-P-positive cells become extinct without giving
rise to foci. This figure is in remarkably good agree-
ment with the estimate above, which is derived from
theoretical considerations.
The mean number of initiated cells at any time
depends on the net rate ofcell division a -P. However,
there is considerable stochastic variation around this
mean number, and this variation depends on a and P3
individually, not just upon their difference. Further,
the distribution of altered cells in foci also depends on
a and 13 individually. Thus, for a given value of a - P,
large values of a and P lead to small numbers of large
foci, and small values of a and 1 lead to large numbers
of small foci. Consider a hypothetical example.
Suppose a- ,B = 0.01 per cell per day, and consider the
following two combinations ofparameters: a = 0.5, ,B =
0.49 and a = 0.1, 13 = 0.09. Both these combinations of
parameters lead to a- 13 = 0.01 and thus to the same
mean number of initiated cells (assuming, of course,
that the rate of initiation is identical). However, the
first set of parameters will lead to a small number of
large foci, whereas the second set will lead to a large
number of small foci. All other things being equal, the
first combination ofparameters carries a higher risk of
malignant transformation than the second. This is
because, in the absence of the compensatory increase
in the rate of repair, a high cell division rate implies a
high mutation rate. Examples of the phenomenon
described here are provided by promoters such as 4-
dimethylaminoazobenzene and the peroxisome prolif-
erators, which lead to a small number oflarge foci, and
others such as N-nitrosodiethanolamine (NDEOL) and
phenobarbital, which lead to a large number of small
foci. By measuring labeling indexes, it should be possi-
ble to confirm that division rates in foci associated with
the former compounds are higher than the division
rates in foci associated with the latter compounds.
The incidence of malignant tumors depends on both
a and 1, not on just their difference. One reason for
this was pointed out above: a large cell division rate
implies a large mutation rate. However, even if the
mutation rates are assumed to be independent of cell
division rates, the incidence function depends on both
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a and 3 individually. This is a simple mathematical
consequence of the model. Thus simulations that take
into account only the mean behavior of cells in the
intermediate compartment (1) lead to erroneous
results forthe incidence ofmalignant tumors.
Inverse Dose-Rate Effect
The inverse dose-rate effect is a curious phenomenon
that has been described with respect to exposure to
high LET radiation and certain chemicals. It involves
fractionation of a given total exposure leading to an
increase in the lifetime risk oftumor. It turns out that
agents that affect cell proliferation kinetics are pre-
dicted to have such an effect. I discuss this in greater
detail below.
An Example. We have used the model presented
above for the analysis ofdata on altered hepatic foci in
rodent hepatocarcinogenesis experiments. It is well
known that the rodent hepatocarcinogenesis model is
characterized by the appearance of foci that exhibit
alterations ofenzyme expression. These foci are clonal,
and at least some ofthem are believed to be premalig-
nant lesions. It seems reasonable to believe that by
studying the temporal evolution of these foci as func-
tions of the doses of the agents under investigation,
one should be able to derive estimates of the parame-
ters relevant to initiation and promotion. I will illus-
trate by means ofa simple example without going into
any technical details, which are given in recent papers
(8,11). In this example, rats were exposed to various
concentrations (0, 0.1, 1, 5, 10, 20,40 ppm) ofN-nitroso-
morpholine (NNM) in their drinking water. The follow-
ing information was available on each animal: the con-
centration of NNM in the drinking water, the age of
the animal when it was sacrificed, the number of
ATPase-deficient foci observed in a two-dimensional
section of the liver, and the area of the examined sec-
tion, the radii in microns of each of the observed foci.
The objective ofthe analysis was to study the effect of
NNM on the parameters of the model and thus to
study the initiation and promotion potencies of the
compound. The relevant expressions required for the
analysis can be found in a recent paper (8). Briefly, the
parameters of the model were estimated by maximiz-
ing the appropriate likelihood function. The results of
the analysis are presented in Figure 2. It can be seen
from the figure that, although there are outliers, the
rates ofinitiation and net proliferation ofinitiated cells
are both linear functions of the dose of NNM. When
the dose response functions are linear, we (8) proposed
the following definitions of initiation and promotion
potencies. Consider the appropriate linear regressions
through the dose-response curves and define the
potency as the quotient ofthe slope and the intercept.
Thus, potency measures the proportionate increase
over background of initiation or promotion per unit of
dose. Potency, as defined here, depends on the units in
which dose is measured; however, once the potency is
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FIGURE 2. Estimated initiation rate /ml /day (IR) and estimated net
promotion rate/cell day (NP) plotted against dose of N-nitroso-
morpholine in parts per million. The fitted lines were used to com-
pute initiating and promoting potencies as described in the text.
computed in a given system ofunits, it is an easy mat-
ter to express it in any other system of units. For the
NNM data, the regression lines are given by IR(d) =
5.9 + 10.93 d, where IR(d) is the number ofcells initiat-
ed per day per milliliter of liver as a function of dose,
and NP(d) = 0.009 + 0.0003 d, where NP(d) is the net
proliferation rate (a - ,) expressed as a function of
dose. It follows that initiating potency is 10.93/5.9 =
1.85 per ppm, and promoting potency is 0.0003/0.009 =
0.034 per ppm. Thus, by these definitions of initiating
and promoting potencies, NNM is a strong initiator
and a weak promoter. These definitions of initiating
and promoting potencies make sense only when the
dose-response functions are linear, and the rates ofini-
tiation and promotion are constant overtime.
The number ofnormal cells per milliliter ofliver that
becomes initiated ranges from about 10 per day in the
control group to about 380 perday in the 40-ppm group.
That is, approximately 3,600 cells are initiated per milli-
liter per year in the control group and 140,000 in the 40-
ppm group. In contrast, the model predicts about 100
nonextinct foci in the control group and about 1,700
nonextinct foci in the 40-ppm group at the end of 1 year
of treatment. Thus the model suggests that the vast
majority of initiated cells dies without giving rise to
foci. These numbers must be taken as rough estimates
derived from the model. Due to technical considerations
beyond the scope of this paper, these estimates could
f
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be made more precise if information were directly
available on cell division rates in the foci.
Explanations for Inverse Dose-Rate Effect. As stat-
ed earlier, an interesting phenomenon observed with
exposure to high LET radiation and to some chemicals
is that fractionation ofa given total exposure results in
an increased lifetime probability of tumor (12). There
are some obvious biological explanations for this phe-
nomenon. For example, ifa chemical needs to be meta-
bolically activated and if high exposure rates lead to
saturation of the relevant enzyme pathway, then one
would expect to see an inverse exposure-rate effect.
Similarly, with radiation, one would expect to see an
inverse exposure-rate effect if a high exposure rate
leads to cell killing. With agents that affect cell prolifer-
ation kinetics, however, an inverse exposure-rate effect
can be predicted even if neither saturation nor cell
killing is taking place. Consider an agent that increases
a - I, and suppose that a - P is a linear function ofthe
exposure of the agent. In particular, suppose that nei-
ther threshold nor saturation phenomena are operat-
ing. Then, mathematical calculations based on the
model in Figure 1 show that the lifetime probability of
tumor is higher with fractionation ofa given total expo-
sure. Another way of stating this fact is that a given
total dose of a promoter is more effective in bringing
about malignant transformation with prolonged appli-
cation. Figure 3 illustrates this situation. Figure 3 is a
plot ofprobability of occurrence ofmalignant tumor as
function oftime after application ofpromoter is begun.
The curves in Figure 3 represent tumor probability for
identical total promoter dose but at different dose
rates. Exposure to promoter is assumed to begin at age
10. The total administered dose is 500 units, and five
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FIGURE 3. Probability of tumor plotted against age for a given total
dose of a promoting agent administered at different dose rates.
The net proliferation rate ofintermediate cells is assumed to be an
increasing linear function of dose rate, and this is assumed to be
due to the promoter decreasing the rate of apoptosis. All other
parameters are assumed to be unaffected by the agent.
different dose rates are shown. Thus, for example, with
dose rate 10, exposure begins at age 10 and continues
until age 60. The parameters assumed for this example
are as follows: vX = 0.1, f/oa = 0.9, a- i = 0.04 + O.Old
where d is the dose rate, and ,u = 10-. It is quite clear
from the figure that, eventually, the probability of
tumor is highest at the lowest dose rate.
Concluding Remarks
The consideration of cell kinetics in models of car-
cinogenesis leads to some surprising and unexpected
results. Perhaps the most important consequence of
considering both cell division and cell death explicitly
is the conclusion that some initiated cells must die
without giving rise to foci. This conclusion also under-
scores the importance of considering not just the net
cell division rate, but cell division and cell death sepa-
rately. Another important consequence is that agents
that increase the net proliferation rate exhibit the
inverse dose-rate effect.
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